Literature DB >> 33542328

Comprehensive characterization and quantification of adeno associated vectors by size exclusion chromatography and multi angle light scattering.

Nicole L McIntosh1, Geoffrey Y Berguig1, Omair A Karim1, Christa L Cortesio1, Rolando De Angelis1, Ayesha A Khan1, Daniel Gold1, John A Maga1, Vikas S Bhat2.   

Abstract

Adeno associated virus (AAV) capsids are a leading modality for in vivo gene delivery. Complete and precise characterization of capsid particles, including capsid and vector genome concentration, is necessary to safely and efficaciously dose patients. Size exclusion chromatography (SEC) coupled to multiangle light scattering (MALS) offers a straightforward approach to comprehensively characterize AAV capsids. The current study demonstrates that this method provides detailed AAV characterization information, including but not limited to aggregation profile, size-distribution, capsid content, capsid molar mass, encapsidated DNA molar mass, and total capsid and vector genome titer. Currently, multiple techniques are required to generate this information, with varying accuracy and precision. In the current study, a new series of equations for SEC-MALS are used in tandem with intrinsic properties of the capsids and encapsidated DNA to quantify multiple physical AAV attributes in one 20-min run with minimal sample manipulation, high accuracy, and high precision. These novel applications designate this well-established method as a powerful tool for product development and process analytics in future gene therapy programs.

Entities:  

Year:  2021        PMID: 33542328     DOI: 10.1038/s41598-021-82599-1

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  30 in total

1.  Evaluation of accuracy and precision of adenovirus absorptivity at 260 nm under conditions of complete DNA disruption.

Authors:  Joyce A Sweeney; John P Hennessey
Journal:  Virology       Date:  2002-04-10       Impact factor: 3.616

2.  Quantitation of encapsidated recombinant adeno-associated virus DNA in crude cell lysates and tissue culture medium by quantitative, real-time PCR.

Authors:  John P Mayginnes; Sharon E Reed; Heath G Berg; Elizabeth M Staley; David J Pintel; Gregory E Tullis
Journal:  J Virol Methods       Date:  2006-07-24       Impact factor: 2.014

3.  OneBac: platform for scalable and high-titer production of adeno-associated virus serotype 1-12 vectors for gene therapy.

Authors:  Mario Mietzsch; Sabrina Grasse; Catherine Zurawski; Stefan Weger; Antonette Bennett; Mavis Agbandje-McKenna; Nicholas Muzyczka; Sergei Zolotukhin; Regine Heilbronn
Journal:  Hum Gene Ther       Date:  2014-01-23       Impact factor: 5.695

4.  Successful attenuation of humoral immunity to viral capsid and transgenic protein following AAV-mediated gene transfer with a non-depleting CD4 antibody and cyclosporine.

Authors:  J H McIntosh; M Cochrane; S Cobbold; H Waldmann; S A Nathwani; A M Davidoff; A C Nathwani
Journal:  Gene Ther       Date:  2011-06-30       Impact factor: 5.250

5.  Systemic errors in quantitative polymerase chain reaction titration of self-complementary adeno-associated viral vectors and improved alternative methods.

Authors:  Paolo Fagone; J Fraser Wright; Amit C Nathwani; Arthur W Nienhuis; Andrew M Davidoff; John T Gray
Journal:  Hum Gene Ther Methods       Date:  2012-02       Impact factor: 2.396

6.  Separation of adeno-associated virus type 2 empty particles from genome containing vectors by anion-exchange column chromatography.

Authors:  Guang Qu; Jennifer Bahr-Davidson; Joseph Prado; Alex Tai; Floro Cataniag; Jennifer McDonnell; Jingmin Zhou; Bernd Hauck; Jac Luna; Jurg M Sommer; Peter Smith; Shangzhen Zhou; Peter Colosi; Katherine A High; Glenn F Pierce; J Fraser Wright
Journal:  J Virol Methods       Date:  2006-12-28       Impact factor: 2.014

7.  Phase 2 clinical trial of a recombinant adeno-associated viral vector expressing α1-antitrypsin: interim results.

Authors:  Terence R Flotte; Bruce C Trapnell; Margaret Humphries; Brenna Carey; Roberto Calcedo; Farshid Rouhani; Martha Campbell-Thompson; Anthony T Yachnis; Robert A Sandhaus; Noel G McElvaney; Christian Mueller; Louis M Messina; James M Wilson; Mark Brantly; David R Knop; Guo-jie Ye; Jeffrey D Chulay
Journal:  Hum Gene Ther       Date:  2011-08-24       Impact factor: 5.695

8.  Size distribution analysis of influenza virus particles using size exclusion chromatography.

Authors:  Judith Vajda; Dennis Weber; Dominik Brekel; Boris Hundt; Egbert Müller
Journal:  J Chromatogr A       Date:  2016-08-26       Impact factor: 4.759

Review 9.  Manufacturing of recombinant adeno-associated viral vectors for clinical trials.

Authors:  Nathalie Clément; Joshua C Grieger
Journal:  Mol Ther Methods Clin Dev       Date:  2016-03-16       Impact factor: 6.698

Review 10.  Emerging Issues in AAV-Mediated In Vivo Gene Therapy.

Authors:  Pasqualina Colella; Giuseppe Ronzitti; Federico Mingozzi
Journal:  Mol Ther Methods Clin Dev       Date:  2017-12-01       Impact factor: 6.698

View more
  8 in total

Review 1.  Gene therapy for kidney disease: targeting cystinuria.

Authors:  Jennifer L Peek; Matthew H Wilson
Journal:  Curr Opin Nephrol Hypertens       Date:  2022-03-01       Impact factor: 2.894

2.  Characterization of the GfaABC1D promoter to selectively target astrocytes in the rhesus macaque brain.

Authors:  Kate S Heffernan; Kazi Rahman; Yoland Smith; Adriana Galvan
Journal:  J Neurosci Methods       Date:  2022-02-22       Impact factor: 2.390

Review 3.  Approaches to Gene Modulation Therapy for ALS.

Authors:  Katharina E Meijboom; Robert H Brown
Journal:  Neurotherapeutics       Date:  2022-09-06       Impact factor: 6.088

Review 4.  Analytical methods to characterize recombinant adeno-associated virus vectors and the benefit of standardization and reference materials.

Authors:  Erica A Green; Kelvin H Lee
Journal:  Curr Opin Biotechnol       Date:  2021-07-15       Impact factor: 10.279

5.  Rapid characterization of adeno-associated virus (AAV) gene therapy vectors by mass photometry.

Authors:  Di Wu; Philsang Hwang; Tiansen Li; Grzegorz Piszczek
Journal:  Gene Ther       Date:  2022-01-20       Impact factor: 4.184

6.  Electrophoresis-Mediated Characterization of Full and Empty Adeno-Associated Virus Capsids.

Authors:  Adriana Coll De Peña; Lucy Masto; James Atwood; Anubhav Tripathi
Journal:  ACS Omega       Date:  2022-06-29

7.  Reverse-Phase Ultra-Performance Chromatography Method for Oncolytic Coxsackievirus Viral Protein Separation and Empty to Full Capsid Quantification.

Authors:  James Z Deng; Richard R Rustandi; Damon Barbacci; Andrew R Swartz; Amanda Gulasarian; John W Loughney
Journal:  Hum Gene Ther       Date:  2022-06-01       Impact factor: 4.793

8.  Retention and Fouling during Nanoparticle Filtration: Implications for Membrane Purification of Biotherapeutics.

Authors:  Liang-Kai Chu; S Ranil Wickramasinghe; Xianghong Qian; Andrew L Zydney
Journal:  Membranes (Basel)       Date:  2022-03-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.